Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Relapsed / Refractory Chronic Lymphocytic Leukemia (CLL) WITH Bendamustine / Mitoxantrone (BM)

NCT00274963 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00274963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Relapsed / Refractory Chronic Lymphocytic Leukemia (CLL) WITH Bendamustine / Mitoxantrone (BM)
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2004
Completion date
October 31, 2009
Enrollment
60 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia